Overall, we suggest that deficiency in TRAF2 or TRAF3 may confer survival advantage to B cells via elevated NF-κB2 that predisposes B cells to lymphomagenesis by permitting them to accumulate low frequency genetic alterations, other than chromosomal translocations, that eventually cause lymphoma. Here, NFKB2 is linked to lymphoma.